WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
What Chinese Consumers Want From Western Retailers(5/23/2018 )  (Premium)
Industry News
Pivotal bioVenture Partners China Closes Inaugural $150M Early Stage VC Fund(5/25/2018 )  (free)
Brii Biosciences Announces Significant Partnerships and Financing(5/25/2018 )  (free)
Karyopharm and Antengene Sign Exclusive License Agreement for Chinese and Select Asian Market(5/24/2018 )  (Premium)
China Approves XiAn Janssen's INVEGA SUSTENNA(5/24/2018 )  (Premium)
WuXi Biologics to Invest to Build a S$80M Manufacturing Facility in Singapore(5/23/2018 )  (free)
A-Share Listed Domestic Pharma Companies Report Q1/2018 Performance(5/23/2018 )  (Premium)
Pfizer's Chinese Urban Hospital Drug Sales Rebounded in 2017(5/23/2018 )  (Premium)
Takeda Sells Majority Stake in JV Techpool to Chinese Partners(5/22/2018 )  (Premium)
Bioasis and WuXi Biologics Enter Strategic Collaboration for Brain Cancer Drug(5/22/2018 )  (Premium)
Salubris Pharma, MedAllliance Enter Investment/Licensing Deal for Novel CVD Therapy(5/22/2018 )  (Premium)
Regulatory News
CNDA and NHC issue Joint Announcement for Optimization of Drug Evaluation and Approval(5/23/2018 )  (Premium)
CFDA Releases Generic Drug Quality and Efficacy Equivalence Evaluation Announcement (Batch 4)(5/22/2018 )  (Premium)
General Health
Mental Health Issues Rise among Chinese Children(5/25/2018 )  (Premium)
MOHRSS Publishes 2017 Human Resources and Social Security Statistical Report, Outlining Essential BMI Information(5/22/2018 )  (Premium)
Five Chinese Agencies Jointly Issue 1st Batch of Rare Disease List(5/22/2018 )  (Premium)
China May Scrap Its Two-child Family Planning Policy(5/22/2018 )  (Premium)
People in the News
Recent Executive Moves(5/25/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links